Chargement en cours...
Advantages and disadvantages of the use of the CSF Amyloid β (Aβ) 42/40 ratio in the diagnosis of Alzheimer’s Disease
The cerebrospinal fluid (CSF) biochemical markers (biomarkers) Amyloidβ 42 (Aβ(42)), total Tau (T-tau) and Tau phosphorylated at threonine 181 (P-tau(181)) have proven diagnostic accuracy for mild cognitive impairment and dementia due to Alzheimer’s Disease (AD). In an effort to improve the accuracy...
Enregistré dans:
| Publié dans: | Alzheimers Res Ther |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BioMed Central
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6477717/ https://ncbi.nlm.nih.gov/pubmed/31010420 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13195-019-0485-0 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|